Abstract
Background: Cases of malignant ovarian tumors consisting of Clear Cell Carcinoma (CCC) and Yolk Sac Tumor (YST) are decidedly rare. Case: We herein report the case of a 58-year-old woman with an ovarian tumor, of which ap- proximately 70 percent was composed of CCC and 30 percent YST. The plan was to utilize a chemotherapeutic regimen of 4 cycles of Bleomycin, Etoposide, Cisplatin (BEP) followed by 4 cycles of Carboplatin/Paclitaxel. Conclusion: No previous cases with an identical combination of CCC and YST have been found in the literature. Because of its rarity, deciding on optimal therapy is challenging.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
